383
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Immunohistochemical analysis of protective effects of maternal fingolimod on the placenta and fetal lung and brain in chorioamnionitis-induced preterm birth rat model

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 564-571 | Received 01 May 2020, Accepted 29 Aug 2020, Published online: 16 Sep 2020

References

  • Burdet J, Rubio AP, Salazar AI, et.al. Inflammation, infection and preterm birth. Curr Pharm Design. 2014;20:4741–4748.
  • Gotsch F, Romero R, Kusanovic JP, et. al. The fetal inflammatory response syndrome. Clin Obstet Gynecol. 2007;50:652–683.
  • Romero R, Chaiworapongsa T, Espinoza J. Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J Nutr. 2003;133 :1668S–1673S.
  • Vrachnis N, Vitoratos N, Iliodromiti Z, et. al. Intrauterine inflammation and preterm delivery. Ann N Y Acad Sci. 2010;1205:118–122.
  • Elitt CM, Rosenberg PA. The challenge of understanding cerebral white matter injury in the premature infant. Neuroscience. 2014;276:216–238.
  • Bashiri A, Burstein E, Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med. 2006;34:5–12.
  • Girard S, Kadhim H, Roy M, et. al. Role of perinatal inflammation in cerebral palsy. Pediatr Neurol. 2009;40:168–174.
  • Burd I, Breen K, Friedman A, et. al. Magnesium sulfate reduces inflammation-associated brain injury in fetal mice. Am J Obstet Gynecol. 2010;202:292.e1–292.e9.
  • Nguyen TM, Crowther CA, Wilkinson D, et. al. Magnesium sulphate for women at term for neuroprotection of the fetus. Cochrane Database Syst Rev. 2013;2:CD009395.
  • Berger R, Soder S. Neuroprotection in preterm infants. BioMed Res Int. 2015;2015:257139.
  • Wei Y, Yemisci M, Kim HH, et. al. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol. 2011;69:119–129.
  • Rolland WB 2nd, Manaenko A, Lekic T, et al. FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice. Acta Neurochir Suppl. 2011;111:213–217.
  • Hasegawa Y, Suzuki H, Sozen T, et. al. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke, 2010;41:368–374.
  • Geissbuhler Y, Hortonada EP, Hashmonay R, et. al. editors. Study design of a multinational Gilenya (fingolimod) pregnancy exposure registry. In: The 27th annual meeting of the CMSC and the 5th cooperative meeting of the CMSC-ACTRIMS, Orlando; 2013.
  • Karlsson G, Francis G, Koren G, et. al. Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology. 2014;82:674–680.
  • Khatri BO, Pelletier J, Kappos L, et. al. TRANSFORMS Study Group. Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS). Mult Scler Relat Disord. 2014;3:355–363.
  • Gelineau-van Waes J., Rainey MA., Maddox JR., et. al. Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720, Birth Defects Research Part A Clinical and Molecular Teratology. 2012;94:790–803.
  • Müller F. O'Rahilly R. The development of the human brain, the closure of the caudal neuropore, and the beginning of secondary neurulation at stage 12. Anat Embryol (Berl). 1987;176:413–430.
  • Shih HJ, Yen JC, Chiu AW, et. al. FTY720 mitigates torsion/detorsion-induced testicular injury in rats. J Surg Res. 2015;196:325–331.
  • Kaur C, Rathnasamy G, Ling EA. Biology of microglia in the developing brain. J Neuropathol Exp Neurol 2017;76:736–753.
  • Garcia A, Masot J, Franco A, et. al. Immunohistochemical evaluation of the goat forestomach during prenatal development. J Vet Sci 2014;15:35–43.
  • Andersson S, Kheiter A, Merritt TA. Oxidative inactivation of surfactants. Lung 1999;177:179–189.
  • Burger D, Ayer JMD. Inhibitory cytokines and cytokine inhibitors. Neurology 1995;45:S39–S43.
  • Arnett HA, Mason J, Marino M, et. al. TNF-α promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 2001;4:1116–1122.
  • Sharp AN, Heazell AEP, Crocker IP, et. al. Placental apoptosis in health and disease. Am J Reprod Immunol. 2010;64:159–169.
  • Yavuz A, Sezik M, Ozmen O, et.al. Fingolimod against LPS-induced fetal brain injury in a rat model. J Obstet Gynaecol Res. 2017;43:1708–1713.
  • Zhao P, Yang X, Yang L, et. al. Neuroprotective effects of fingolimod in mouse models of Parkinson’s disease. FASEB J. 2017;31:172–179.
  • Aytan N, Choi JK, Carreras I, et. al. Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer’s disease. Sci Rep. 2016;6:24939.
  • Serdar M, Herz J, Kempe K, et. al. Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia. Brain Behav Immun. 2016;52:106–119.
  • Xu HL, Pelligrino DA, Paisansathan C, et. al. Protective role of fingolimod (FTY720) in rats subjected to subarachnoid hemorrhage. J Neuroinflammation. 2015;12:16.
  • Maxwell JR, Denson JL, Joste NE, et. al. Combined in utero hypoxia-ischemia and lipopolysaccharide administration in rats induces chorioamnionitis and a fetal inflammatory response syndrome. Placenta. 2015;36:1378–1384.
  • Lu L, Barfejani AH, Qin T, et. al. Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage. Brain Res. 2014;1555:89–96.
  • Brinkmann V, Davis MD, Heise CE, et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem. 2002;277:21453–21457.
  • Dunlap KA, White BG, Erikson DW, et. al. FTY720, a sphingosine analog, altered placentome histoarchitecture in ewes. J Anim Sci Biotech. 2020;11:2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.